2017 annual financial data
Puma Biotechnology 2017 Net margin
Direct answer
Net margin was -1,054.15%.
Operating income was -292,400,000 USD and net income was -292,000,000 USD.
Operating cash flow was -172,500,000 USD.
Get free Puma Biotechnology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 27,700,000 USD
- Operating income
- -292,400,000 USD
- Net income
- -292,000,000 USD
- Operating cash flow
- -172,500,000 USD